Skip to main content
Fig. 5 | Cell Communication and Signaling

Fig. 5

From: Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases

Fig. 5

(a) A compound known as a “lectibody” is created when the IgG crystallizable Fc and lectin of an antibody are combined. (b) Through the actions of CDC, ADCC, and ADCP, lectibodies’ lectins bind to surface glycoproteins, neutralizing viruses or infected cells and assisting the innate and adaptive immune systems in combating pathogens. Reprinted with permission from ref. [138]. Copyright 2022, Springer Nature

Back to article page